Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Oramed Pharmaceuticals (ORMP) has provided an announcement.
David Silberman has stepped down from his roles as CFO, Treasurer, and Secretary at Oramed Pharmaceuticals Inc. for personal reasons, with his resignation effective from July 12, 2024. The company is actively looking for a new CFO to fill the vacancy.
Find detailed analytics on ORMP stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money